Annual Short Term Debt
$300.80 K
-$109.20 K-26.63%
31 December 2023
Summary:
CNS Pharmaceuticals annual short term debt is currently $300.80 thousand, with the most recent change of -$109.20 thousand (-26.63%) on 31 December 2023. During the last 3 years, it has fallen by -$138.50 thousand (-31.53%). CNSP annual short term debt is now -31.53% below its all-time high of $439.30 thousand, reached on 31 December 2020.CNSP Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$31.20 K
-$92.00 K-74.68%
30 September 2024
Summary:
CNS Pharmaceuticals quarterly short term debt is currently $31.20 thousand, with the most recent change of -$92.00 thousand (-74.68%) on 30 September 2024. Over the past year, it has dropped by -$10.70 thousand (-25.54%). CNSP quarterly short term debt is now -92.90% below its all-time high of $439.30 thousand, reached on 31 December 2020.CNSP Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNSP Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -26.6% | -25.5% |
| 3 y3 years | -31.5% | -30.0% |
| 5 y5 years | -5.1% | -89.6% |
CNSP Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -31.5% | at low | -92.4% | at low |
| 5 y | 5 years | -31.5% | -92.9% | ||
| alltime | all time | -31.5% | -92.9% |
CNS Pharmaceuticals Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $31.20 K(-74.7%) |
| June 2024 | - | $123.20 K(-42.2%) |
| Mar 2024 | - | $213.10 K(-29.2%) |
| Dec 2023 | $300.80 K(-26.6%) | $300.80 K(+617.9%) |
| Sept 2023 | - | $41.90 K(-74.8%) |
| June 2023 | - | $166.40 K(-42.4%) |
| Mar 2023 | - | $289.10 K(-29.5%) |
| Dec 2022 | $410.00 K | $410.00 K(+943.3%) |
| Sept 2022 | - | $39.30 K(-74.9%) |
| June 2022 | - | $156.40 K(-42.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $272.60 K(-29.7%) |
| Dec 2021 | $387.80 K(-11.7%) | $387.80 K(+769.5%) |
| Sept 2021 | - | $44.60 K(-74.9%) |
| June 2021 | - | $177.60 K(-42.5%) |
| Mar 2021 | - | $309.10 K(-29.6%) |
| Dec 2020 | $439.30 K(>+9900.0%) | $439.30 K(>+9900.0%) |
| Dec 2019 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 2019 | - | $300.00 K(0.0%) |
| June 2019 | - | $300.00 K(-5.3%) |
| Dec 2018 | $316.90 K(+160.2%) | $316.90 K |
| Dec 2017 | $121.80 K | - |
FAQ
- What is CNS Pharmaceuticals annual short term debt?
- What is the all time high annual short term debt for CNS Pharmaceuticals?
- What is CNS Pharmaceuticals annual short term debt year-on-year change?
- What is CNS Pharmaceuticals quarterly short term debt?
- What is the all time high quarterly short term debt for CNS Pharmaceuticals?
- What is CNS Pharmaceuticals quarterly short term debt year-on-year change?
What is CNS Pharmaceuticals annual short term debt?
The current annual short term debt of CNSP is $300.80 K
What is the all time high annual short term debt for CNS Pharmaceuticals?
CNS Pharmaceuticals all-time high annual short term debt is $439.30 K
What is CNS Pharmaceuticals annual short term debt year-on-year change?
Over the past year, CNSP annual short term debt has changed by -$109.20 K (-26.63%)
What is CNS Pharmaceuticals quarterly short term debt?
The current quarterly short term debt of CNSP is $31.20 K
What is the all time high quarterly short term debt for CNS Pharmaceuticals?
CNS Pharmaceuticals all-time high quarterly short term debt is $439.30 K
What is CNS Pharmaceuticals quarterly short term debt year-on-year change?
Over the past year, CNSP quarterly short term debt has changed by -$10.70 K (-25.54%)